住院患者静脉输液药学干预在妇幼保健院中的实践与探讨

    Pharmaceutical Intervention in Intravenous Infusion for Inpatients: Practices and Explorations in Maternal and Child Health Hospitals

    • 摘要:
      目的  探讨通过药学干预规范妇幼保健院住院患者静脉输液的成效。
      方法 抽取2022年8月—2024年7月余姚市妇幼保健院34861例住院患者作为研究对象,根据患者住院时间分为对照组(2022年8月—2023年7月)和干预组(2023年8月—2024年7月),其中对照组15655例,干预组19206 例。 比较干预前和干预后住院患者静脉输液各项指标的差异。
      结果 采取药学干预措施后,干预组较对照组降低了住院患者的静脉输液率,指标差异有统计学意义(P<0.05),住院患者静脉输液各项指标有效下降。
      结论 药学干预措施能有效降低住院患者静脉输液率,规范住院患者静脉输液,促进合理用药,保障患者用药安全性、有效性和经济性。

       

      Abstract:
      OBJECTIVE To explore the effect of standardizing the intravenous infusion of hospitalized patients in maternal and child health institutions in the region through pharmaceutical intervention.
      METHODS Selected 34861 hospitalized patients from Yuyao Maternal and Child Health Hospital in the region from August 2022 to July 2024 as research objects. The patients were divided into control group(August 2022 to July 2023) and intervention group(August 2023 to July 2024) according to the hospitalization time, with 15655 cases in the control group and 19206 cases in the intervention group. The differences of the indicators of intravenous infusion in hospitalized patients before and after intervention were compared.
      RESULTS After taking pharmaceutical intervention measures, the intravenous infusion rate of hospitalized patients in the intervention group was reduced compared with the control group, and the difference was statistically significant(P<0.05), the indicators of intravenous infusion in hospitalized patients decreased effectively.
      CONCLUSION Pharmaceutical intervention measures can effectively reduce the rate of intravenous infusion in hospitalized patients, standardize intravenous infusion in hospitalized patients, improve rational drug use, and ensure the safety, effectiveness and economy of drug use in patients.

       

    /

    返回文章
    返回